TLR4 and diabetic retinopathy: Hsa-miR-145-5p was down-regulated in high glucose-treated retinal endothelial cells (a cellular model of diabetic retinopathy), and hsa-miR-145-5p overexpression significantly reduced TLR4 at both the protein and mRNA levels (74).